Amgen to Buy Onyx for $10.4 Billion - New York Times

Top Stories
What's going on? 
Eventbrite makes it happen

Create an event and sell tickets online through Eventbrite. It's simple! Sign up and get started today.
From our sponsors
Amgen to Buy Onyx for $10.4 Billion - New York Times
Aug 26th 2013, 15:40


New York Times

Amgen to Buy Onyx for $10.4 Billion
New York Times
Onyx's oldest drug is Nexavar, which is approved to treat liver and kidney cancers. Bayer and Onyx PharmaceuticalsOnyx's oldest drug is Nexavar, which is approved to treat liver and kidney cancers. Although Amgen is the world's biggest biotechnology ...
Clarification: Amgen-Onyx storyWashington Post
US STOCKS-Wall St advances as durables data reduces Fed worryReuters
Amgen's Onyx Takeover Is Symptom of Deeper Pharma SicknessBloomberg
The Myeloma Beacon -Kansas City Star
all 205 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments: